ERIS
Invest with MTF
Invest Now
Invest in Eris Lifesciences with 3.31X leverage
Performance
- Low
- ₹1,390
- High
- ₹1,511
- 52 Week Low
- ₹1,097
- 52 Week High
- ₹1,910
- Open Price₹1,511
- Previous Close₹1,510
- Volume238,365
- 50 DMA₹1,480.85
- 100 DMA₹1,528.07
- 200 DMA₹1,530.52
Investment Returns
- Over 1 Month -4.24%
- Over 3 Month -6.83%
- Over 6 Month -15.55%
- Over 1 Year + 11.8%
Smart Investing Starts Here Start SIP with Eris Lifesciences for Steady Growth!
Eris Lifesciences Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 45.4
- PEG Ratio
- 1.5
- Market Cap Cr
- 19,593
- P/B Ratio
- 6.3
- Average True Range
- 52.57
- EPS
- 30.02
- Dividend Yield
- 0
- MACD Signal
- -19.07
- RSI
- 45.02
- MFI
- 46.65
Eris Lifesciences Financials
Eris Lifesciences Technicals
EMA & SMA
Current Price
₹1,414.40
-96
(-6.36%)
- Bearish Moving Average 15
- Bullish Moving Average 1
- 20 Day
- ₹1,441.27
- 50 Day
- ₹1,480.85
- 100 Day
- ₹1,528.07
- 200 Day
- ₹1,530.52
Resistance and Support
1438.43
- R3 1,608.07
- R2 1,559.53
- R1 1,486.97
- S1 1,365.87
- S2 1,317.33
- S3 1,244.77
Eris Lifesciences Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2026-02-13 | Quarterly Results | |
| 2025-11-24 | Preferential issue of shares | Inter-alia, To consider the protposal of issuance ofequity shares of the Company by way of a preferential issue for consideration other than cash.. per share(601%)Interim Dividend |
| 2025-11-12 | Quarterly Results | |
| 2025-08-05 | Quarterly Results | |
| 2025-05-19 | Audited Results |
Eris Lifesciences F&O
About Eris Lifesciences
- NSE Symbol
- ERIS
- BSE Symbol
- 540596
- Chairperson & Managing Director
- Mr. Amit Bakshi
- ISIN
- INE406M01024
Similar Stocks to Eris Lifesciences
Eris Lifesciences FAQs
Eris Lifesciences share price is ₹1,414 As on 14 February, 2026 | 14:33
The Market Cap of Eris Lifesciences is ₹19592.7 Cr As on 14 February, 2026 | 14:33
The P/E ratio of Eris Lifesciences is 45.4 As on 14 February, 2026 | 14:33
The PB ratio of Eris Lifesciences is 6.3 As on 14 February, 2026 | 14:33
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.